Trials / Recruiting
RecruitingNCT07082244
Implant Phenotype Modification Via GBR and ADM
Phenotype Modification Via Guided Bone Regeneration and Acellular Dermal Matrix Simultaneous to Delayed Implant Placement: A Double Arm Randomized Controlled Clinical Trial.
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- University of Michigan · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Single implant sites with bone loss can often be managed by bone grafting alone. The purpose of this study is to determine whether putting a soft tissue graft substitute over the bone graft will provide an increased benefit for improving the health, appearance, and stability of the bone and gums surrounding the implant.
Detailed description
The study will treat patients that need a single implant at a previously edentulous site (\>3 months post extraction) that requires phenotypic modification. These patients will receive an implant with simultaneous GBR, with half of the participants also receiving an ADM graft.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Dental implant placement | Participants will have a dental implant placed at a toothless site |
| PROCEDURE | Guided bone regeneration with collagen membrane | Participants will receive guided bone regeneration at a toothless site with bone substitute and a collagen membrane. |
| PROCEDURE | Guided bone regeneration with acellular dermal matrix. | Participants will receive guided bone regeneration at a toothless site with bone substitute and an acellular dermal matrix. |
Timeline
- Start date
- 2025-06-01
- Primary completion
- 2026-07-01
- Completion
- 2026-09-01
- First posted
- 2025-07-24
- Last updated
- 2025-08-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07082244. Inclusion in this directory is not an endorsement.